319 related articles for article (PubMed ID: 26175470)
21. Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort.
Arnold MB; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
Rheumatology (Oxford); 2014 Jun; 53(6):1075-86. PubMed ID: 24501240
[TBL] [Abstract][Full Text] [Related]
22. [Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis].
Avdeeva AS; Aleksandrova EN; Novikov AA; Cherkasova MV; Panasyuk EY; Nasonov EL
Ter Arkh; 2013; 85(5):24-9. PubMed ID: 23819335
[TBL] [Abstract][Full Text] [Related]
23. Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.
Gamboa-Cárdenas RV; Ugarte-Gil MF; Loreto M; Sacnun MP; Saurit V; Cardiel MH; Soriano ER; Pisoni C; Galarza-Maldonado CM; Rios C; Radominski SC; Castelar-Pinheiro GDR; Bianchi WA; Appenzeller S; da Silveira IG; de Freitas Zerbini CA; Caballero-Uribe CV; Rojas-Villarraga A; Guibert-Toledano M; Ballesteros F; Montufar R; Vázquez-Mellado J; Esquivel-Valerio J; De La Torre IG; Barile-Fabris LA; Palezuelos FI; Andrade-Ortega L; Monge P; Teijeiro R; Achurra-Castillo ÁF; Esteva Spinetti MH; Alarcón GS; Pons-Estel BA
Clin Rheumatol; 2019 Oct; 38(10):2737-2746. PubMed ID: 31161486
[TBL] [Abstract][Full Text] [Related]
24. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
[TBL] [Abstract][Full Text] [Related]
25. Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal: A Prospective Observational Cohort Study from Southern Sweden.
Einarsson JT; Geborek P; Saxne T; Kristensen LE; Kapetanovic MC
J Rheumatol; 2016 Jun; 43(6):1017-23. PubMed ID: 27036384
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
[TBL] [Abstract][Full Text] [Related]
27. Comparison of three rheumatoid arthritis disease activity scores in clinical routine.
Rintelen B; Sautner J; Haindl PM; Andel I; Maktari A; Leeb BF
Scand J Rheumatol; 2009; 38(5):336-41. PubMed ID: 19585379
[TBL] [Abstract][Full Text] [Related]
28. DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt.
Martins FM; da Silva JA; Santos MJ; Vieira-Sousa E; Duarte C; Santos H; Costa JA; Pimentel-Santos FM; Cunha I; Cunha Miranda L; Nóvoa T; Cruz M; Bernardes M; Araujo D; Pereira Silva JA; Silva JC; Branco JC; Gomes JA; Faustino A; Fonseca JE; Canhão H
Rheumatology (Oxford); 2015 Feb; 54(2):286-91. PubMed ID: 25173347
[TBL] [Abstract][Full Text] [Related]
29. Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow-ups and predictors of achieving treatment target.
Xiang Y; Wang Q; Li H; Duan X; Fang Y; Yang P; Li Q; Wu R; Huo Y; Shi X; Wu Z; Wang Y; Jiang N; Hsieh E; Li M; Tian X; Zeng X;
Int J Rheum Dis; 2020 Dec; 23(12):1719-1727. PubMed ID: 33034424
[TBL] [Abstract][Full Text] [Related]
30. Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE).
Sugihara T; Ishizaki T; Hosoya T; Iga S; Yokoyama W; Hirano F; Miyasaka N; Harigai M
Rheumatology (Oxford); 2015 May; 54(5):798-807. PubMed ID: 25296748
[TBL] [Abstract][Full Text] [Related]
31. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
Kaneko Y; Kondo H; Takeuchi T
J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
[TBL] [Abstract][Full Text] [Related]
32. Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study.
da Silva Chakr RM; Brenol JC; Behar M; Mendonça JA; Kohem CL; Monticielo OA; Brenol CV; Xavier RM
PLoS One; 2015; 10(3):e0118620. PubMed ID: 25738587
[TBL] [Abstract][Full Text] [Related]
33. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
[TBL] [Abstract][Full Text] [Related]
34. Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.
Haugeberg G; Hansen IJ; Soldal DM; Sokka T
Arthritis Res Ther; 2015 Aug; 17(1):219. PubMed ID: 26290061
[TBL] [Abstract][Full Text] [Related]
35. Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort.
Mueller RB; Kaegi T; Finckh A; Haile SR; Schulze-Koops H; von Kempis J;
Rheumatology (Oxford); 2014 Apr; 53(4):671-7. PubMed ID: 24352338
[TBL] [Abstract][Full Text] [Related]
36. Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort.
Sewerin P; Vordenbaeumen S; Hoyer A; Brinks R; Buchbender C; Miese F; Schleich C; Klein S; Schneider M; Ostendorf B
BMC Musculoskelet Disord; 2017 Apr; 18(1):163. PubMed ID: 28420375
[TBL] [Abstract][Full Text] [Related]
37. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
[TBL] [Abstract][Full Text] [Related]
38. Reexamination of the assessment criteria for rheumatoid arthritis disease activity based on comparison of the Disease Activity Score 28 with other simpler assessment methods.
Fujiwara M; Kita Y
Mod Rheumatol; 2013 Mar; 23(2):260-8. PubMed ID: 22546955
[TBL] [Abstract][Full Text] [Related]
39. GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate.
Castrejón I; Pincus T; Soubrier M; Lin YC; Rat AC; Combe B; Dougados M
Rheumatology (Oxford); 2013 Oct; 52(10):1890-7. PubMed ID: 23864169
[TBL] [Abstract][Full Text] [Related]
40. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
